Zobrazeno 1 - 10 of 150 pro vyhledávání: '"Pancani, E."'
1
Akademický článek
Sentenza 23 settembre 1965; Pres. Thermes P. P., Est. Pedata; Cucci (Avv. Cocchi) c. Nardi (Avv. Pancani) e Min. giustizia
Publikováno v: Il Foro Italiano, 1966 Apr 01. 89(4), 735/736-737/738.
Externí odkaz: https://www.jstor.org/stable/23155638
Zobrazit plný text záznamu
3
Akademický článek
Three-in-one: exploration of co-encapsulation of cabazitaxel, bicalutamide and chlorin e6 in new mixed cyclodextrin-crosslinked polymers.
Autor: Pancani E; Institute for Organic Synthesis and Photoreactivity (ISOF), National Research Council of Italy (CNR) Via P. Gobetti 101 I-40129 Bologna Italy ilse.manet@isof.cnr.it., Veclani D; Institute for Organic Synthesis and Photoreactivity (ISOF), National Research Council of Italy (CNR) Via P. Gobetti 101 I-40129 Bologna Italy ilse.manet@isof.cnr.it., Agnes M; Institute for Organic Synthesis and Photoreactivity (ISOF), National Research Council of Italy (CNR) Via P. Gobetti 101 I-40129 Bologna Italy ilse.manet@isof.cnr.it., Mazza A; Institute for Organic Synthesis and Photoreactivity (ISOF), National Research Council of Italy (CNR) Via P. Gobetti 101 I-40129 Bologna Italy ilse.manet@isof.cnr.it., Venturini A; Institute for Organic Synthesis and Photoreactivity (ISOF), National Research Council of Italy (CNR) Via P. Gobetti 101 I-40129 Bologna Italy ilse.manet@isof.cnr.it., Malanga M; CycloLab, Cyclodextrin R&D Ltd. Budapest Hungary., Manet I; Institute for Organic Synthesis and Photoreactivity (ISOF), National Research Council of Italy (CNR) Via P. Gobetti 101 I-40129 Bologna Italy ilse.manet@isof.cnr.it.
Publikováno v: RSC advances [RSC Adv] 2023 Apr 06; Vol. 13 (16), pp. 10923-10939. Date of Electronic Publication: 2023 Apr 06 (Print Publication: 2023).
Zobrazit plný text záznamu
4
Akademický článek
Implementation of Water-Soluble Cyclodextrin-Based Polymers in Biomedical Applications: How Far Are We?
Autor: Agnes M; Istituto per la Sintesi Organica e la Fotoreattività (ISOF), Consiglio Nazionale delle Ricerche (CNR), via P. Gobetti 101, Bologna, 40129, Italy., Pancani E; Istituto per la Sintesi Organica e la Fotoreattività (ISOF), Consiglio Nazionale delle Ricerche (CNR), via P. Gobetti 101, Bologna, 40129, Italy., Malanga M; CycloLab, Cyclodextrin R&D Ltd., Budapest, H1097, Hungary., Fenyvesi E; CycloLab, Cyclodextrin R&D Ltd., Budapest, H1097, Hungary., Manet I; Istituto per la Sintesi Organica e la Fotoreattività (ISOF), Consiglio Nazionale delle Ricerche (CNR), via P. Gobetti 101, Bologna, 40129, Italy.
Publikováno v: Macromolecular bioscience [Macromol Biosci] 2022 Aug; Vol. 22 (8), pp. e2200090. Date of Electronic Publication: 2022 May 02.
Zobrazit plný text záznamu
5
Akademický článek
Intrinsic Antibacterial Activity of Nanoparticles Made of β-Cyclodextrins Potentiates Their Effect as Drug Nanocarriers against Tuberculosis.
Autor: Machelart A; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France., Salzano G; Université Paris Sud, Université Paris-Saclay , CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO) , F-91405 Orsay , France., Li X; Université Paris Sud, Université Paris-Saclay , CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO) , F-91405 Orsay , France., Demars A; Research Unit in Microorganisms Biology (URBM), Laboratory of Immunology and Microbiology , Université de Namur , Narilis , B-5000 Namur , Belgium., Debrie AS; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France., Menendez-Miranda M; Université Paris Sud, Université Paris-Saclay , CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO) , F-91405 Orsay , France., Pancani E; Université Paris Sud, Université Paris-Saclay , CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO) , F-91405 Orsay , France., Jouny S; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France., Hoffmann E; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France., Deboosere N; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France., Belhaouane I; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France., Rouanet C; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France., Simar S; Université de Lille , Institut Pasteur de Lille , EA 4483, F-59000 Lille , France., Talahari S; Université de Lille , Institut Pasteur de Lille , EA 4483, F-59000 Lille , France., Giannini V; Institut Pasteur , Unit for Integrated Mycobacterial Pathogenomics, Paris , CNRS UMR 3525, 25 Rue du Dr. Roux , F-75015 Paris , France., Villemagne B; Université de Lille , INSERM, Institut Pasteur de Lille , U1177 - Drugs and Molecules for living Systems, F-59000 Lille , France., Flipo M; Université de Lille , INSERM, Institut Pasteur de Lille , U1177 - Drugs and Molecules for living Systems, F-59000 Lille , France., Brosch R; Institut Pasteur , Unit for Integrated Mycobacterial Pathogenomics, Paris , CNRS UMR 3525, 25 Rue du Dr. Roux , F-75015 Paris , France., Nesslany F; Université de Lille , Institut Pasteur de Lille , EA 4483, F-59000 Lille , France., Deprez B; Université de Lille , INSERM, Institut Pasteur de Lille , U1177 - Drugs and Molecules for living Systems, F-59000 Lille , France., Muraille E; Research Unit in Microorganisms Biology (URBM), Laboratory of Immunology and Microbiology , Université de Namur , Narilis , B-5000 Namur , Belgium.; Laboratory of Parasitology, Faculty of Medicine , Université Libre de Bruxelles , B-1070 Brussels , Belgium., Locht C; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France., Baulard AR; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France., Willand N; Université de Lille , INSERM, Institut Pasteur de Lille , U1177 - Drugs and Molecules for living Systems, F-59000 Lille , France., Majlessi L; Institut Pasteur , Unit for Integrated Mycobacterial Pathogenomics, Paris , CNRS UMR 3525, 25 Rue du Dr. Roux , F-75015 Paris , France., Gref R; Université Paris Sud, Université Paris-Saclay , CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO) , F-91405 Orsay , France., Brodin P; Université de Lille , CNRS, INSERM, CHU Lille, Institut Pasteur de Lille , U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000 Lille , France.
Publikováno v: ACS nano [ACS Nano] 2019 Apr 23; Vol. 13 (4), pp. 3992-4007. Date of Electronic Publication: 2019 Mar 08.
Zobrazit plný text záznamu
6
Akademický článek
How to unravel the chemical structure and component localization of individual drug-loaded polymeric nanoparticles by using tapping AFM-IR.
Autor: Mathurin J; Laboratoire de Chimie Physique (LCP), CNRS UMR 8000, Univ. of Paris-Sud, Université Paris-Saclay, 91405 Orsay, France. alexandre.dazzi@u-psud.fr., Pancani E, Deniset-Besseau A, Kjoller K, Prater CB, Gref R, Dazzi A
Publikováno v: The Analyst [Analyst] 2018 Dec 03; Vol. 143 (24), pp. 5940-5949.
Zobrazit plný text záznamu
7
Publisher Correction: Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles.
Autor: Costa-Gouveia J; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Pancani E; University of Paris-Sud, University Paris-Saclay, CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO), 91405, Orsay, France., Jouny S; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Machelart A; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Delorme V; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Salzano G; University of Paris-Sud, University Paris-Saclay, CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO), 91405, Orsay, France., Iantomasi R; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Piveteau C; Univ. Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000, Lille, France., Queval CJ; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Song OR; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Flipo M; Univ. Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000, Lille, France., Deprez B; Univ. Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000, Lille, France., Saint-André JP; University Hospital Center of Angers, 49000, Angers, France., Hureaux J; University Hospital Center of Angers, 49000, Angers, France., Majlessi L; Pathogénomique Mycobactérienne Intégrée, Département de Génomes et Génétique, Institut Pasteur, Paris, France., Willand N; Univ. Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000, Lille, France., Baulard A; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Brodin P; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France. priscille.brodin@inserm.fr., Gref R; University of Paris-Sud, University Paris-Saclay, CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO), 91405, Orsay, France. ruxandra.gref@u-psud.fr.
Publikováno v: Scientific reports [Sci Rep] 2018 May 10; Vol. 8 (1), pp. 7596. Date of Electronic Publication: 2018 May 10.
Zobrazit plný text záznamu
8
Akademický článek
Nanoparticles with high payloads of pipemidic acid, a poorly soluble crystalline drug: drug-initiated polymerization and self-assembly approach.
Autor: Pancani E; Institut de Sciences Moléculaires d'Orsay (ISMO), Univ. of Paris-Sud, Université Paris-Saclay, Orsay 91405, France., Menendez-Miranda M; Institut de Sciences Moléculaires d'Orsay (ISMO), Univ. of Paris-Sud, Université Paris-Saclay, Orsay 91405, France., Pastor A; Institut de Sciences Moléculaires d'Orsay (ISMO), Univ. of Paris-Sud, Université Paris-Saclay, Orsay 91405, France.; Institut Galien, UMR8612 Univ. of Paris-Sud, Université Paris-Saclay, Châtenay-Malabry 92290, France., Brisset F; Institut de Chimie Moléculaire et des Matériaux d'Orsay (ICMMO), Univ. of Paris-Sud, Université Paris-Saclay, Orsay 91405, France., Bernet-Camard MF; EA4043 'Unité Bactéries Pathogènes et Santé' (UBaPS), Univ. of Paris-Sud, Université Paris-Saclay, Châtenay-Malabry 92290, France., Desmaële D; Institut Galien, UMR8612 Univ. of Paris-Sud, Université Paris-Saclay, Châtenay-Malabry 92290, France., Gref R; Institut de Sciences Moléculaires d'Orsay (ISMO), Univ. of Paris-Sud, Université Paris-Saclay, Orsay 91405, France.
Publikováno v: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2018 May; Vol. 8 (3), pp. 420-431. Date of Electronic Publication: 2018 Mar 27.
Zobrazit plný text záznamu
9
Akademický článek
Efficient loading of ethionamide in cyclodextrin-based carriers offers enhanced solubility and inhibition of drug crystallization.
Autor: Wankar J; Istituto per la Sintesi Organica e la Fotoreattività, ISOF, CNR, via P. Gobetti 101, 40129 Bologna, Italy., Salzano G; Institut des Sciences Moléculaires d'Orsay (ISMO), UMR CNRS 8214, Univ. Paris-Sud, Université Paris-Saclay, 91405 Orsay, France., Pancani E; Institut des Sciences Moléculaires d'Orsay (ISMO), UMR CNRS 8214, Univ. Paris-Sud, Université Paris-Saclay, 91405 Orsay, France., Benkovics G; CycloLab, Cyclodextrin R&D Ltd., H1097 Budapest, Hungary., Malanga M; CycloLab, Cyclodextrin R&D Ltd., H1097 Budapest, Hungary., Manoli F; Istituto per la Sintesi Organica e la Fotoreattività, ISOF, CNR, via P. Gobetti 101, 40129 Bologna, Italy., Gref R; Institut des Sciences Moléculaires d'Orsay (ISMO), UMR CNRS 8214, Univ. Paris-Sud, Université Paris-Saclay, 91405 Orsay, France., Fenyvesi E; CycloLab, Cyclodextrin R&D Ltd., H1097 Budapest, Hungary., Manet I; Istituto per la Sintesi Organica e la Fotoreattività, ISOF, CNR, via P. Gobetti 101, 40129 Bologna, Italy. Electronic address: ilse.manet@isof.cnr.it.
Publikováno v: International journal of pharmaceutics [Int J Pharm] 2017 Oct 15; Vol. 531 (2), pp. 568-576. Date of Electronic Publication: 2017 May 22.
Zobrazit plný text záznamu
10
Akademický článek
Combination therapy for tuberculosis treatment: pulmonary administration of ethionamide and booster co-loaded nanoparticles.
Autor: Costa-Gouveia J; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Pancani E; University of Paris-Sud, University Paris-Saclay, CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO), 91405, Orsay, France., Jouny S; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Machelart A; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Delorme V; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Salzano G; University of Paris-Sud, University Paris-Saclay, CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO), 91405, Orsay, France., Iantomasi R; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Piveteau C; Univ. Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000, Lille, France., Queval CJ; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Song OR; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Flipo M; Univ. Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000, Lille, France., Deprez B; Univ. Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000, Lille, France., Saint-André JP; University Hospital Center of Angers, 49000, Angers, France., Hureaux J; University Hospital Center of Angers, 49000, Angers, France., Majlessi L; Pathogénomique Mycobactérienne Intégrée, Département de Génomes et Génétique, Institut Pasteur, Paris, France., Willand N; Univ. Lille, INSERM, Institut Pasteur de Lille, U1177 - Drugs and Molecules for living Systems, F-59000, Lille, France., Baulard A; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France., Brodin P; Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, F-59000, Lille, France. priscille.brodin@inserm.fr., Gref R; University of Paris-Sud, University Paris-Saclay, CNRS, UMR 8214 - Institute for Molecular Sciences of Orsay (ISMO), 91405, Orsay, France. ruxandra.gref@u-psud.fr.
Publikováno v: Scientific reports [Sci Rep] 2017 Jul 14; Vol. 7 (1), pp. 5390. Date of Electronic Publication: 2017 Jul 14.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje